Authors: Leather, H Wingard, J

Citation: H. Leather et J. Wingard, Caspofungin - A viewpoint by Helen Leather and John Wingard, DRUGS, 61(8), 2001, pp. 1131-1131

Authors: Jones, R Horowitz, M Wall, D Wingard, J Wolff, S McCarthy, P Hahn, T

Citation: R. Jones et al., ASBMT policy statement regarding the methodology of evidence-based reviewsin evaluating the role of blood and marrow transplantation in the treatment of selected diseases, BIOL BLOOD, 6(5), 2000, pp. 524-525

Authors: Andersson, BS Gajewski, J Donato, M Giralt, S Gian, V Wingard, J Tarantolo, S Fernandez, H Hu, WW Blume, K Kashyap, A Forman, SJ Champlin, RE

Citation: Bs. Andersson et al., Allogeneic stem cell transplantation (BMT) for AML and MDS following i.v. busulfan and cyclophosphamide (i.v. BuCy), BONE MAR TR, 25, 2000, pp. S35-S38

Authors: Baker, F Zabora, J Polland, A Wingard, J

Citation: F. Baker et al., Reintegration after bone marrow transplantation, CANCER PRAC, 7(4), 1999, pp. 190-197

Authors: Waples, JM Moreb, JS Sugrue, M Belanger, G Kubilis, P Lynch, JW Gian, V Weeks, F Wingard, J

Citation: Jm. Waples et al., Comparison of autologous peripheral blood stem cell dosing by ideal vs actual body weight, BONE MAR TR, 23(9), 1999, pp. 867-873